C000232435 Fees and Costs — Direxion mRNA ETF
Data updated: 2023-06-29
The net expense ratio is 0.65%: a 0.60% management fee plus 0.05% other expenses. There are no sales loads or redemption fees. In fiscal 2022 the fund paid $3K in broker commissions, 0.0934% of average net assets, and portfolio turnover was 85%.
C000232435 Fees and Expenses
Annual operating expenses and sales charges of C000232435. Prospectus, as of February 28, 2023.
| Annual operating expenses | |
|---|---|
| Management fee | 0.60% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.05% |
| Gross expense ratio | 0.65% |
| Fee waiver | — |
| Net expense ratio | 0.65% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
C000232435 Costs Over Time
On $10,000 invested in C000232435, assuming 5% a year before costs, total costs come to $467 over 5 years, cutting the return by 0.78% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.65%) | $68 | $214 | $371 |
| Trading costs (broker commissions) | $10 | $31 | $53 |
| Lost growth on money paid in costs | $0 | $12 | $43 |
| Total costs | $78 | $256 | $467 |
| Value after costs | $10,422 | $11,320 | $12,295 |
| Impact on return, per year | 0.78% | 0.78% | 0.78% |
C000232435 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending October 31, 2022.
- Explicit cost rate (commissions ÷ average net assets): 0.0934%
- Total broker commissions: $3K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 85%
- Securities on loan, average value: $125K
- Net income from securities lending: $12K (0.392% of average net assets)
C000232435 Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Credit Suisse Securities (USA) LLC | $3K | 100.00% |
| BNY Mellon Capital Markets, LLC | $0 | 0.00% |
| CL SECURITIES TAIWAN COMPANY LIMITED | $0 | 0.00% |
| KOREA INVESTMENT AND SECURITIES CO., LTD | $0 | 0.00% |
| Pershing LLC | $0 | 0.00% |
| BNP Paribas | $0 | 0.00% |
| ADM Investor Services, Inc. | $0 | 0.00% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.